Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Reply to Soteriadou et al.

Dave M, Purohit T, Razonable RR, Loftus EV.

Inflamm Bowel Dis. 2014 Feb;20(2):E5-6. doi: 10.1097/01.MIB.0000438431.23176.5d. No abstract available.

PMID:
24374883
2.

The "Q" of fever in inflammatory bowel disease.

Soteriadou S, Blanchard T, Limdi JK.

Inflamm Bowel Dis. 2014 Feb;20(2):E4-5. doi: 10.1097/01.MIB.0000438426.41102.12. No abstract available.

PMID:
24374882
3.

Risk of infections with biological agents.

Kopylov U, Afif W.

Gastroenterol Clin North Am. 2014 Sep;43(3):509-24. doi: 10.1016/j.gtc.2014.05.001. Epub 2014 Jun 16. Review.

PMID:
25110256
4.

Opportunistic infections due to inflammatory bowel disease therapy.

Dave M, Purohit T, Razonable R, Loftus EV Jr.

Inflamm Bowel Dis. 2014 Jan;20(1):196-212. doi: 10.1097/MIB.0b013e3182a827d2. Review.

PMID:
24051931
5.

Immunosuppressive monoclonal antibodies: current and next generation.

Focosi D, Maggi F, Pistello M, Boggi U, Scatena F.

Clin Microbiol Infect. 2011 Dec;17(12):1759-68. doi: 10.1111/j.1469-0691.2011.03677.x. Epub 2011 Oct 13. Review.

6.

[Recommendations on tuberculosis and treatment of inflammatory bowel disease with infliximab. 2006 update].

López-San Román A, Obrador A, Fortún J, Muñoz P, Gassull MA; Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU).

Gastroenterol Hepatol. 2006 Feb;29(2):81-4. Spanish. No abstract available.

PMID:
16448610
7.

Opportunistic infections in paediatric inflammatory bowel disease patients.

De Greef E, Vandenplas Y, Veereman-Wauters G.

Arch Dis Child. 2012 Jan;97(1):5-7. doi: 10.1136/archdischild-2011-300365. Epub 2011 Sep 7. Review. No abstract available.

PMID:
21903596
8.

Inflammatory bowel disease and infection concerns.

[No authors listed]

Mayo Clin Health Lett. 2008 Aug;26(8):4. No abstract available.

PMID:
18802973
9.

Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis.

Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF.

Gut. 2008 Apr;57(4):549-58. doi: 10.1136/gut.2006.114660. Epub 2008 Jan 4. Review.

PMID:
18178610
10.

IBD: incidence of HSV and HPV with azathioprine.

Cottone M, Renna S.

Nat Rev Gastroenterol Hepatol. 2009 Aug;6(8):444-5. doi: 10.1038/nrgastro.2009.110. No abstract available.

PMID:
19654597
11.

Varicella zoster exposure in patients with inflammatory bowel disease--recall is not enough.

Aggarwal D, Limdi JK.

Am J Gastroenterol. 2014 Mar;109(3):448-9. doi: 10.1038/ajg.2013.378. No abstract available.

PMID:
24594962
12.

Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease.

Shale MJ, Seow CH, Coffin CS, Kaplan GG, Panaccione R, Ghosh S.

Aliment Pharmacol Ther. 2010 Jan;31(1):20-34. doi: 10.1111/j.1365-2036.2009.04112.x. Epub . Review.

13.

Prevalence, predictive factors and ideal treatment of cytomegalovirus infection in IBD patients.

Köroğlu E, Çelik AF.

Turk J Gastroenterol. 2012;23 Suppl 2:35-40. Review. No abstract available.

14.

Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.

Gisbert JP, Chaparro M, Esteve M.

Aliment Pharmacol Ther. 2011 Mar;33(6):619-33. Review.

PMID:
21416659
15.

Methods to avoid infections in patients with inflammatory bowel disease.

Aberra FN, Lichtenstein GR.

Inflamm Bowel Dis. 2005 Jul;11(7):685-95. Review.

PMID:
15973124
16.

Letter: dermatological complications with therapy for inflammatory bowel disease--authors' reply.

Ghosh S, Moran GW.

Aliment Pharmacol Ther. 2014 Jan;39(2):233-4. doi: 10.1111/apt.12572. No abstract available.

17.

Viral infections associated with the clinical use of monoclonal antibodies.

Gentile G, Foà R.

Clin Microbiol Infect. 2011 Dec;17(12):1769-75. doi: 10.1111/j.1469-0691.2011.03680.x. Epub 2011 Oct 25. Review.

18.

Response to Tung et al.

Chaparro M, Gisbert JP.

Am J Gastroenterol. 2013 Apr;108(4):621-2. doi: 10.1038/ajg.2013.34. No abstract available.

PMID:
23552315
19.

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ.

Gastroenterology. 2008 Apr;134(4):929-36. doi: 10.1053/j.gastro.2008.01.012. Epub 2008 Jan 11.

PMID:
18294633
20.

[Consensus guideline on tuberculosis and treatment of inflammatory bowel disease with infliximab. Spanish Working Group on Crohn Disease and Ulcerative Colitis].

Obrador A, López San Román A, Muñoz P, Fortún J, Gassull MA; Grupo Español de Trabajo de Enfermedad de Crohn y Colitis Ulcerosa (GETECCU).

Gastroenterol Hepatol. 2003 Jan;26(1):29-33. Review. Spanish. No abstract available.

PMID:
12525326
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk